Logo image of CENX

CENTURY ALUMINUM COMPANY (CENX) Stock Fundamental Analysis

NASDAQ:CENX - Nasdaq - US1564311082 - Common Stock - Currency: USD

18.47  +0.3 (+1.65%)

After market: 18.47 0 (0%)

Fundamental Rating

3

Overall CENX gets a fundamental rating of 3 out of 10. We evaluated CENX against 150 industry peers in the Metals & Mining industry. CENX has a medium profitability rating, but doesn't score so well on its financial health evaluation. CENX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CENX was profitable.
CENX had a positive operating cash flow in the past year.
CENX had negative earnings in each of the past 5 years.
Of the past 5 years CENX 4 years had a positive operating cash flow.
CENX Yearly Net Income VS EBIT VS OCF VS FCFCENX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M

1.2 Ratios

CENX has a better Return On Assets (16.13%) than 96.50% of its industry peers.
The Return On Equity of CENX (46.91%) is better than 98.60% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.56%, CENX is in the better half of the industry, outperforming 66.43% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CENX is significantly below the industry average of 8.75%.
The 3 year average ROIC (2.82%) for CENX is below the current ROIC(5.56%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 16.13%
ROE 46.91%
ROIC 5.56%
ROA(3y)-4.65%
ROA(5y)-5.63%
ROE(3y)-18.45%
ROE(5y)-17.98%
ROIC(3y)2.82%
ROIC(5y)N/A
CENX Yearly ROA, ROE, ROICCENX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20 -30

1.3 Margins

With an excellent Profit Margin value of 14.55%, CENX belongs to the best of the industry, outperforming 86.01% of the companies in the same industry.
The Operating Margin of CENX (4.80%) is comparable to the rest of the industry.
The Gross Margin of CENX (7.52%) is worse than 63.64% of its industry peers.
Industry RankSector Rank
OM 4.8%
PM (TTM) 14.55%
GM 7.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CENX Yearly Profit, Operating, Gross MarginsCENX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10 -15

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CENX is destroying value.
Compared to 1 year ago, CENX has more shares outstanding
Compared to 5 years ago, CENX has more shares outstanding
The debt/assets ratio for CENX has been reduced compared to a year ago.
CENX Yearly Shares OutstandingCENX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
CENX Yearly Total Debt VS Total AssetsCENX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

CENX has an Altman-Z score of 1.04. This is a bad value and indicates that CENX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.04, CENX is doing worse than 75.52% of the companies in the same industry.
A Debt/Equity ratio of 0.70 indicates that CENX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.70, CENX is not doing good in the industry: 83.92% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Altman-Z 1.04
ROIC/WACC0.51
WACC10.97%
CENX Yearly LT Debt VS Equity VS FCFCENX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

CENX has a Current Ratio of 1.71. This is a normal value and indicates that CENX is financially healthy and should not expect problems in meeting its short term obligations.
CENX's Current ratio of 1.71 is on the low side compared to the rest of the industry. CENX is outperformed by 64.34% of its industry peers.
CENX has a Quick Ratio of 1.71. This is a bad value and indicates that CENX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CENX (0.56) is worse than 88.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 0.56
CENX Yearly Current Assets VS Current LiabilitesCENX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 356.41% over the past year.
CENX shows a decrease in Revenue. In the last year, the revenue decreased by -4.60%.
CENX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.91% yearly.
EPS 1Y (TTM)356.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%584.62%
Revenue 1Y (TTM)-4.6%
Revenue growth 3Y10.83%
Revenue growth 5Y2.91%
Sales Q2Q%-1.12%

3.2 Future

Based on estimates for the next years, CENX will show a very strong growth in Earnings Per Share. The EPS will grow by 77.51% on average per year.
The Revenue is expected to grow by 5.02% on average over the next years.
EPS Next Y237.26%
EPS Next 2Y160.03%
EPS Next 3Y77.51%
EPS Next 5YN/A
Revenue Next Year-2.19%
Revenue Next 2Y2.43%
Revenue Next 3Y5.02%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CENX Yearly Revenue VS EstimatesCENX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B
CENX Yearly EPS VS EstimatesCENX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 2

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.47, the valuation of CENX can be described as rather expensive.
CENX's Price/Earnings ratio is a bit cheaper when compared to the industry. CENX is cheaper than 70.63% of the companies in the same industry.
CENX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.47.
CENX is valuated reasonably with a Price/Forward Earnings ratio of 8.81.
Based on the Price/Forward Earnings ratio, CENX is valued cheaper than 83.92% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 92.74, CENX is valued rather cheaply.
Industry RankSector Rank
PE 18.47
Fwd PE 8.81
CENX Price Earnings VS Forward Price EarningsCENX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CENX.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.52
CENX Per share dataCENX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CENX's earnings are expected to grow with 77.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y160.03%
EPS Next 3Y77.51%

0

5. Dividend

5.1 Amount

No dividends for CENX!.
Industry RankSector Rank
Dividend Yield N/A

CENTURY ALUMINUM COMPANY

NASDAQ:CENX (2/4/2025, 8:00:00 PM)

After market: 18.47 0 (0%)

18.47

+0.3 (+1.65%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)02-20 2025-02-20/amc
Inst Owners61.9%
Inst Owner Change-0.5%
Ins Owners0.85%
Ins Owner Change0.29%
Market Cap1.71B
Analysts82.22
Price Target24.48 (32.54%)
Short Float %9.46%
Short Ratio4.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)4.76%
Min Revenue beat(2)-1.34%
Max Revenue beat(2)10.85%
Revenue beat(4)2
Avg Revenue beat(4)3.05%
Min Revenue beat(4)-2.59%
Max Revenue beat(4)10.85%
Revenue beat(8)5
Avg Revenue beat(8)3.89%
Revenue beat(12)6
Avg Revenue beat(12)1.5%
Revenue beat(16)6
Avg Revenue beat(16)-0.21%
PT rev (1m)4.35%
PT rev (3m)26.32%
EPS NQ rev (1m)5.95%
EPS NQ rev (3m)242.31%
EPS NY rev (1m)-1.44%
EPS NY rev (3m)50.74%
Revenue NQ rev (1m)-1.93%
Revenue NQ rev (3m)-3.11%
Revenue NY rev (1m)-0.51%
Revenue NY rev (3m)-1.29%
Valuation
Industry RankSector Rank
PE 18.47
Fwd PE 8.81
P/S 0.82
P/FCF N/A
P/OCF 20.7
P/B 2.63
P/tB 2.63
EV/EBITDA 11.52
EPS(TTM)1
EY5.41%
EPS(NY)2.1
Fwd EY11.35%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)0.89
OCFY4.83%
SpS22.65
BVpS7.03
TBVpS7.03
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.13%
ROE 46.91%
ROCE 7.08%
ROIC 5.56%
ROICexc 5.69%
ROICexgc 5.69%
OM 4.8%
PM (TTM) 14.55%
GM 7.52%
FCFM N/A
ROA(3y)-4.65%
ROA(5y)-5.63%
ROE(3y)-18.45%
ROE(5y)-17.98%
ROIC(3y)2.82%
ROIC(5y)N/A
ROICexc(3y)2.95%
ROICexc(5y)N/A
ROICexgc(3y)2.95%
ROICexgc(5y)N/A
ROCE(3y)3.59%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Debt/EBITDA 2.47
Cap/Depr 120.43%
Cap/Sales 4.82%
Interest Coverage 2.88
Cash Conversion 44.76%
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 0.56
Altman-Z 1.04
F-Score6
WACC10.97%
ROIC/WACC0.51
Cap/Depr(3y)115.08%
Cap/Depr(5y)86.6%
Cap/Sales(3y)3.74%
Cap/Sales(5y)3.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)356.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%584.62%
EPS Next Y237.26%
EPS Next 2Y160.03%
EPS Next 3Y77.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.6%
Revenue growth 3Y10.83%
Revenue growth 5Y2.91%
Sales Q2Q%-1.12%
Revenue Next Year-2.19%
Revenue Next 2Y2.43%
Revenue Next 3Y5.02%
Revenue Next 5YN/A
EBIT growth 1Y461.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year293.17%
EBIT Next 3Y88.2%
EBIT Next 5YN/A
FCF growth 1Y81.92%
FCF growth 3Y-28.91%
FCF growth 5YN/A
OCF growth 1Y1700%
OCF growth 3Y35.02%
OCF growth 5YN/A